PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 259 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $59,113,896 | +107383.7% | 2,066,197 | +9.8% | 0.10% | +16.3% |
Q1 2024 | $54,998 | -5.0% | 1,882,197 | +9.6% | 0.09% | -4.4% |
Q4 2023 | $57,921 | +17.0% | 1,716,697 | +6.4% | 0.09% | +7.1% |
Q3 2023 | $49,517 | -21.5% | 1,613,997 | +2.5% | 0.08% | -7.7% |
Q2 2023 | $63,098 | -0.8% | 1,574,697 | +1.0% | 0.09% | +8.3% |
Q1 2023 | $63,619 | +3.8% | 1,558,897 | -1.8% | 0.08% | 0.0% |
Q4 2022 | $61,278 | -99.9% | 1,587,097 | -9.5% | 0.08% | -36.4% |
Q3 2022 | $93,269,000 | -18.6% | 1,753,497 | -10.8% | 0.13% | -2.9% |
Q2 2022 | $114,588,000 | -19.3% | 1,965,497 | +5.6% | 0.14% | -18.6% |
Q1 2022 | $142,031,000 | +27.6% | 1,860,997 | +0.6% | 0.17% | +21.0% |
Q4 2021 | $111,266,000 | +0.9% | 1,849,197 | -6.1% | 0.14% | -2.8% |
Q3 2021 | $110,253,000 | -11.8% | 1,968,797 | -4.4% | 0.14% | -9.0% |
Q2 2021 | $125,021,000 | -22.9% | 2,060,327 | -11.0% | 0.16% | -22.8% |
Q1 2021 | $162,244,000 | +3.3% | 2,314,797 | -11.8% | 0.20% | +18.1% |
Q4 2020 | $157,084,000 | -6.0% | 2,625,059 | -5.6% | 0.17% | +2.4% |
Q3 2020 | $167,139,000 | +11.7% | 2,780,097 | -2.5% | 0.17% | +29.5% |
Q2 2020 | $149,581,000 | +80.7% | 2,850,797 | +15.5% | 0.13% | +61.2% |
Q1 2020 | $82,757,000 | +1.6% | 2,468,142 | +37.3% | 0.08% | +27.0% |
Q4 2019 | $81,419,000 | +76.0% | 1,797,338 | +47.9% | 0.06% | +61.5% |
Q3 2019 | $46,259,000 | -2.6% | 1,215,100 | +11.3% | 0.04% | -7.1% |
Q2 2019 | $47,500,000 | +17.3% | 1,092,200 | +2.7% | 0.04% | +13.5% |
Q1 2019 | $40,481,000 | +164.8% | 1,063,600 | +199.4% | 0.04% | +117.6% |
Q4 2018 | $15,285,000 | +318.5% | 355,300 | +378.2% | 0.02% | +325.0% |
Q3 2018 | $3,652,000 | -84.3% | 74,305 | -85.4% | 0.00% | -84.6% |
Q4 2017 | $23,277,000 | +65.5% | 509,900 | +36.2% | 0.03% | +52.9% |
Q3 2017 | $14,062,000 | +1556.3% | 374,500 | +2003.9% | 0.02% | +1600.0% |
Q2 2017 | $849,000 | +4.3% | 17,800 | -29.4% | 0.00% | 0.0% |
Q4 2016 | $814,000 | -4.1% | 25,200 | +1.6% | 0.00% | -50.0% |
Q3 2016 | $849,000 | -27.7% | 24,800 | -28.7% | 0.00% | 0.0% |
Q2 2016 | $1,174,000 | -73.7% | 34,800 | -67.9% | 0.00% | -81.8% |
Q3 2015 | $4,459,000 | +413.1% | 108,500 | +1007.1% | 0.01% | +450.0% |
Q4 2014 | $869,000 | -77.5% | 9,800 | -75.4% | 0.00% | -81.8% |
Q3 2014 | $3,857,000 | -67.9% | 39,800 | -76.8% | 0.01% | -62.1% |
Q1 2014 | $12,003,000 | +192.0% | 171,500 | +139.9% | 0.03% | +190.0% |
Q4 2013 | $4,111,000 | – | 71,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Doma Perpetual Capital Management LLC | 1,000,761 | $28,631,772 | 13.28% |
GAGNON SECURITIES LLC | 596,591 | $17,068,469 | 3.84% |
Sio Capital Management, LLC | 455,500 | $13,031,855 | 3.53% |
Gagnon Advisors, LLC | 133,390 | $3,816,288 | 2.91% |
AlphaCentric Advisors LLC | 117,500 | $3,361,675 | 2.48% |
ARDSLEY ADVISORY PARTNERS LP | 580,000 | $16,593,800 | 2.44% |
RICE HALL JAMES & ASSOCIATES, LLC | 998,625 | $28,570,661 | 1.71% |
Lisanti Capital Growth, LLC | 138,830 | $3,971,926 | 0.96% |
Bridge City Capital, LLC | 84,856 | $2,427,730 | 0.82% |
Rock Springs Capital Management LP | 785,000 | $22,458,850 | 0.68% |